Current understanding of complement proteins as therapeutic targets for the treatment of immunoglobulin a nephropathy

A Rajasekaran, TJ Green, MB Renfrow, BA Julian… - Drugs, 2023 - Springer
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide and a frequent cause of kidney failure. Currently, the diagnosis necessitates a …
被引用次数：1 相关文章

Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

A Rajasekaran, TJ Green, MB Renfrow, BA Julian… - Drugs - pubmed.ncbi.nlm.nih.gov
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide and a frequent cause of kidney failure. Currently, the diagnosis necessitates a …

Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.

A Rajasekaran, TJ Green, MB Renfrow, BA Julian… - Drugs, 2023 - europepmc.org
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide and a frequent cause of kidney failure. Currently, the diagnosis necessitates a …
[HTML] nih.gov

[HTML][HTML] Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

A Rajasekaran, TJ Green, MB Renfrow, BA Julian… - Drugs, 2023 - ncbi.nlm.nih.gov
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide and a frequent cause of kidney failure. Currently, the diagnosis necessitates a …

Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.

A Rajasekaran, TJ Green, MB Renfrow, BA Julian… - Drugs, 2023 - europepmc.org
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide and a frequent cause of kidney failure. Currently, the diagnosis necessitates a …